Andersons pediatric cardiology 1596

erythematosus.AmJDisChild.1984;138:663–
666.
345.ScottJS,MaddisonPJ,TaylorPV,etal.
Connective-tissuedisease,antibodiesto
ribonucleoprotein,andcongenitalheartblock.N
EnglJMed.1983;309(4):209–212.
346.Costedoat-ChalumeauN,AmouraZ,
LupoglazoffJM,etal.Outcomeofpregnancies
inpatientswithAnti-SSA/roantibodies:astudy
of165pregnancies,withspecialfocuson
electrocardiographicvariationsinthechildren
andcomparisonwithacontrolgroup.Arthritis
Rheum.2004;50(10):3187–3194.
347.BuyonJP,HiebertR,CopelJ,etal.
Autoimmune-associatedcongenitalheartblock:
demographics,mortality,morbidityand
recurrenceratesobtainedfromanational
neonatallupusregistry.JAmCollCardiol.
1998;31(7):1658–1666.
348.Costedoat-ChalumeauN,AmouraZ,VillainE,
CohenL,PietteJC.Anti-SSA/roantibodiesand
theheart:morethancompleteheartblock?A
reviewofelectrocardiographicandmyocardial
abnormalitiesandoftreatmentoptions.Arthritis
ResTher.2005;7(2):69–73.
349.IzmirlyPM,Costedoat-ChalumeauN,Pisona
CN,etal.Maternaluseofhydroxychloroquineis


associatedwithareducedriskofrecurrentantiSSA/ro-antibody-associatedcardiac
manifestationsofneonatallupus.Circulation.

2013;126(12):76–82.
350.TaliercioCP,OlneyBA,LieJT.Myocarditis
relatedtodrughypersensitivity.MayoClinProc.
1985;60:463–468.
351.BillinghamME.Morphologicchangesindrug
inducedheartdisease.BristowMR.Drug
InducedHeartDisease.Elsevier:Amsterdam;
1980:127–149.
352.CaoK,CapellBC,ErdosMR,DjabaliK,Collins
FS.Alaminaproteinisoformoverexpressedin
Hutchinson-gilfordprogeriasyndromeinterferes
withmitosisinprogeriaandnormalcells.Proc
NatlAcadSciUSA.2007;104(12):4949–4954.
353.OliveM,HartenI,MitchellR,etal.
CardiovascularpathologyinHutchinson-gilford
progeria:correlationwiththevascularpathology
ofaging.ArteriosclerThrombVascBiol.
2010;30(11):2301–2309.
354.DeBuskF.Progeria.BehrmanRE,VaughanVC.
Nelson'sTextbookofPediatrics.Saunders:
Philadelphia,PA;1983:1776–1777.
355.BakerPB,BabaN,BoeselCP.Cardiovascular
abnormalitiesinprogeria.Casereportand
reviewoftheliterature.ArchPatholLabMed.


1981;105:384–386.
356.AlagilleD,OdievreM,GautierM,Dommergues
JP.Hepaticductularhypoplasiaassociatedwith
characteristicfacies,vertebralmalformations,

retardedphysical,mentalandsexual
developmentandacardiacmurmur.JPediatr.
1975;86:63–71.
357.MuellerRF,PagonRA,PepinMG,etal.
Arteriohepaticdysplasia:phenotypicfeatures
andfamilystudies.ClinGenet.1984;25:323–
331.
358.LiL,KrantzID,DengY,etal.Alagille
syndromeiscausedbymutationsinhuman
jagged1,whichencodesaligandfornotch1.Nat
Genet.1997;16(3):212–213.
359.KamathBM,SpinnerNB,EmerickKM,etal.
Vascularanomaliesinalagillesyndrome:a
significantcauseofmorbidityandmortality.
Circulation.2004;109(11):1354–1358.
360.EmerickKA,RandEB,GoldmuntzE,etal.
Featuresofallagillesyndromein92patients:
frequencyandrelationtoprognosis.Hepatology.
1999;29(3):822–829.
361.EmerickKA,RandEB,GoldmuntzE,etal.
Featuresofallagillesyndromein92patients:
frequencyandrelationtoprognosis.Hepatology.
1999;29(3):822–829.